Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Metabolic fingerprints" of cachexia in lung cancer patients.
Frille A, Arends J, Abenavoli EM, Duke SA, Ferrara D, Gruenert S, Hacker M, Hesse S, Hofmann L, Holm SH, Lund TB, Rullmann M, Sandøe P, Sciagrà R, Shiyam Sundar LK, Tönjes A, Wirtz H, Yu J, Sabri O, Beyer T; (the LuCaPET consortium). Frille A, et al. Among authors: sabri o. Eur J Nucl Med Mol Imaging. 2024 Mar 20. doi: 10.1007/s00259-024-06689-8. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38504039 No abstract available.
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group. Barthel H, et al. Among authors: sabri o. Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8. Lancet Neurol. 2011. PMID: 21481640 Clinical Trial.
Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function.
Meindl M, Zatcepin A, Gnörich J, Scheifele M, Zaganjori M, Groß M, Lindner S, Schaefer R, Simmet M, Roemer S, Katzdobler S, Levin J, Höglinger G, Bischof AC, Barthel H, Sabri O, Bartenstein P, Saller T, Franzmeier N, Ziegler S, Brendel M. Meindl M, et al. Among authors: sabri o. Eur J Nucl Med Mol Imaging. 2024 May 8. doi: 10.1007/s00259-024-06741-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38717592
The Apparent Diffusion Coefficient of the Paraspinal and Psoas Muscles Are of Prognostic Relevance in Patients With Hepatocellular Carcinoma Undergoing Transarterial Radioembolization.
Ehrengut C, Schindler A, Seehofer D, Ebel S, Steinhoff K, Sabri O, Berg T, Denecke T, Bömmel FV, Meyer HJ. Ehrengut C, et al. Among authors: sabri o. Cancer Diagn Progn. 2024 May 3;4(3):281-287. doi: 10.21873/cdp.10321. eCollection 2024 May-Jun. Cancer Diagn Progn. 2024. PMID: 38707727 Free PMC article.
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [18F]PI-2620.
Bischof GN, Brendel M, Barthel H, Theis H, Barbe M, Bartenstein P, Claasen J, Danek A, Höglinger G, Levin J, Marek K, Neumaier B, Palleis C, Patt M, Rullmann M, Saur D, Schroeter ML, Seibyl J, Song M, Stephens A, Sabri O, Drzezga A, van Eimeren T; German Imaging Initiative for Tauopathies. Bischof GN, et al. Among authors: sabri o. J Nucl Med. 2024 Apr 4:jnumed.123.265930. doi: 10.2967/jnumed.123.265930. Online ahead of print. J Nucl Med. 2024. PMID: 38575191
Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies.
Ferschmann C, Messerschmidt K, Gnörich J, Barthel H, Marek K, Palleis C, Katzdobler S, Stockbauer A, Fietzek U, Finze A, Biechele G, Rumpf JJ, Saur D, Schroeter ML, Rullmann M, Beyer L, Eckenweber F, Wall S, Schildan A, Patt M, Stephens A, Classen J, Bartenstein P, Seibyl J, Franzmeier N, Levin J, Höglinger GU, Sabri O, Brendel M, Scheifele M; German Imaging Initiative for Tauopathies (GII4T). Ferschmann C, et al. Among authors: sabri o. Eur J Nucl Med Mol Imaging. 2024 Feb 17. doi: 10.1007/s00259-024-06637-6. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38366196
Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS.
Palleis C, Franzmeier N, Weidinger E, Bernhardt AM, Katzdobler S, Wall S, Ferschmann C, Harris S, Schmitt J, Schuster S, Gnörich J, Finze A, Biechele G, Lindner S, Albert NL, Bartenstein P, Sabri O, Barthel H, Rupprecht R, Nuscher B, Stephens AW, Rauchmann BS, Perneczky R, Haass C, Brendel M, Levin J, Höglinger GU. Palleis C, et al. Among authors: sabri o. Neurology. 2024 Jan 9;102(1):e207901. doi: 10.1212/WNL.0000000000207901. Epub 2023 Dec 14. Neurology. 2024. PMID: 38165362
Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial.
Pötzsch C, Kurch L, Naumann S, Georgi TW, Sabri O, Stoevesandt D, Cepelova M, Körholz D, Mauz-Körholz C, Hasenclever D, Kluge R. Pötzsch C, et al. Among authors: sabri o. Sci Rep. 2023 Dec 11;13(1):21944. doi: 10.1038/s41598-023-48871-2. Sci Rep. 2023. PMID: 38081864 Free PMC article. Clinical Trial.
418 results